// App-Quantinova.ai

955 : Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Researchers

Presenter

  • Sreenivasulu Chintala

Principal Investigators

  • Remi Adelaiye-Ogala

  • Ashley Orillion

  • Sreevani Arisa

  • May Elbanna

  • Roberto Pili

Medical Centers

  • Genitourinary Program, Division of Hematology & Oncology, IU Melvin and Simon Bren Cancer Center, Indiana University School of Medicine, Indianapolis, IN.

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Clear cell renal carcinoma

  • Solid malignancies

Biomarkers

  • Vascular endothelial growth factor A

  • X-Ray Repair Cross Complementing 1

Drug/Treatment

  • Bevacizumab

  • Vorinostat

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved